与异性性别女性相比,在未使用过毒品的跨性别男性中,与高雄性相关的代谢变化:一项病例对照研究
Pınar Erel1, Onur Elbasan2, Neşe Yorguner3
1Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Türkiye.
Endokrynologia Polska
|August 14, 2023
概括
与女性相比,吸毒的跨性别男性表现出更高的雌激素水平和代谢变化. 需要进一步的研究,以了解这种人群中高雄性质的原因.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 性别研究是性别研究.
背景情况:
- 性别失调症的病因仍然不清楚.
- 之前对跨性别男性雄激素水平的研究使用了未经选择的人群.
- 这项研究侧重于选定的一组未曾使用过毒品的人群.
研究的目的:
- 评价和比较药物素朴的跨性别男性与 cisgender 妇女的荷尔蒙特征和代谢状态.
- 为了调查人体测量,代谢和内分泌学参数.
- 这是同类型的第一个病例控制研究.
主要方法:
- 单中心观察队列研究.
- 纳入了70名未曾吸毒过的跨性别男性和34名健康的女性.
- 测量和比较荷尔蒙配置文件和代谢参数.
主要成果:
- 与 cisgender 女性相比,跨性别男性的总体,自由雄激素指数,androstenedione,17-hydroxyprogesterone,肌肉强度,甘油三和胰岛素抵抗水平更高.
- 16名跨性别男性 (22.85%) 被诊断患有多囊性卵巢综合征 (PCOS),而对照组中有4名 (11.7%).
- 即使在排除PCOS患者后,跨性别男性中也明显出现过高雄性.
结论:
- 跨性别男性表现出明显更高的雄激素水平比 cisgender 女性.
- 较高的雄激素水平可能导致观察到的代谢变化.
- 药物素朴的跨性别男性中高雄性质的主要原因需要进一步调查.
相关概念视频
Factors Affecting Drug Biotransformation: Biological
178
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
178
Menopause
201
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
201
Signs of Puberty
423
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
423
Testosterone: Functions and Regulation
745
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
745
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
279
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
279
Drug Biotransformation: Overview
640
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
640


